Thyroid-stimulating hormone receptor inverse agonists (NIDDK/NCATS)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameThyroid-stimulating hormone receptor inverse agonists (NIDDK/NCATS)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid stimulating hormone receptor agonists
TargetsThyroid stimulating hormone receptor
Therapy Area/IndicationsHyperthyroidismThyroid Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Diabetes And Digestive And Kidney Diseases
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Institute Of Diabetes And Digestive And Kidney Diseases
Active IndicationsN/A
Inactive IndicationsHyperthyroidismThyroid Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A